Paris - Delayed Quote EUR

bioMérieux S.A. (BIM.PA)

Compare
110.00
+3.80
+(3.58%)
At close: 5:35:19 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,806,300.00
3,674,600.00
3,589,000.00
3,376,200.00
3,118,100.00
Cost of Revenue
1,685,600.00
1,617,400.00
1,580,400.00
1,375,400.00
1,364,500.00
Gross Profit
2,120,700.00
2,057,200.00
2,008,600.00
2,000,800.00
1,753,600.00
Operating Expense
1,534,600.00
1,488,300.00
1,382,900.00
1,156,800.00
1,141,200.00
Operating Income
586,100.00
568,900.00
625,700.00
844,000.00
612,400.00
Net Non Operating Interest Income Expense
-5,500.00
-2,800.00
-5,200.00
-6,100.00
-22,000.00
Pretax Income
512,500.00
437,500.00
580,500.00
774,500.00
524,400.00
Tax Provision
113,400.00
114,500.00
140,100.00
175,600.00
121,500.00
Net Income Common Stockholders
411,300.00
357,600.00
452,400.00
601,100.00
404,400.00
Diluted NI Available to Com Stockholders
411,300.00
357,600.00
452,400.00
601,100.00
404,400.00
Basic EPS
3.49
3.03
3.84
5.08
3.42
Diluted EPS
3.47
3.01
3.82
5.06
3.41
Basic Average Shares
118,001.27
118,154.23
117,946.15
118,265.38
118,146.54
Diluted Average Shares
118,791.94
118,802.46
118,440.60
118,893.29
118,652.07
Total Operating Income as Reported
519,500.00
439,000.00
587,200.00
784,300.00
552,800.00
Total Expenses
3,220,200.00
3,105,700.00
2,963,300.00
2,532,200.00
2,505,700.00
Net Income from Continuing & Discontinued Operation
411,300.00
357,600.00
452,400.00
601,100.00
404,400.00
Normalized Income
465,266.11
453,244.80
485,037.00
649,274.91
454,570.42
Interest Income
900.00
1,100.00
1,200.00
1,700.00
1,500.00
Interest Expense
5,400.00
4,400.00
4,100.00
9,100.00
24,900.00
Net Interest Income
-5,500.00
-2,800.00
-5,200.00
-6,100.00
-22,000.00
EBIT
517,900.00
441,900.00
584,600.00
783,600.00
549,300.00
EBITDA
726,600.00
700,800.00
832,600.00
1,031,400.00
760,100.00
Reconciled Cost of Revenue
1,685,600.00
1,617,400.00
1,580,400.00
1,375,400.00
1,364,500.00
Reconciled Depreciation
208,700.00
258,900.00
248,000.00
247,800.00
210,800.00
Net Income from Continuing Operation Net Minority Interest
411,300.00
357,600.00
452,400.00
601,100.00
404,400.00
Total Unusual Items Excluding Goodwill
-69,300.00
-129,600.00
-43,000.00
-62,300.00
-65,300.00
Total Unusual Items
-69,300.00
-129,600.00
-43,000.00
-62,300.00
-65,300.00
Normalized EBITDA
795,900.00
830,400.00
875,600.00
1,093,700.00
825,400.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-15,333.89
-33,955.20
-10,363.00
-14,125.09
-15,129.58
12/31/2020 - 7/7/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LALPATHLAB.BO Dr. Lal PathLabs Limited
2,863.20
-2.09%
 
LBIRD.PA Lumibird SA
9.42
-4.66%
 
ERF.PA Eurofins Scientific SE
49.01
-0.12%
 
DIA.MI DiaSorin S.p.A.
101.45
-1.31%
 
QGEN Qiagen N.V.
45.65
+2.17%
 
ICLR ICON Public Limited Company
215.97
-1.03%
 
IDXX IDEXX Laboratories, Inc.
415.35
-0.65%
 
GH Guardant Health, Inc.
37.01
+0.83%
 
ILMN Illumina, Inc.
142.35
+4.14%
 
DHR Danaher Corporation
239.07
+1.70%